Sukhen C Ghosh
Overview
Explore the profile of Sukhen C Ghosh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
576
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Momeny M, AghaAmiri S, Vargas S, Acidi B, Ghosh S, Bateman T, et al.
Cancers (Basel)
. 2025 Jan;
17(2.
PMID: 39857944
Background: While the clinical use of radiolabeled somatostatin analogs is well established in neuroendocrine tumors, there is growing interest in expanding their application to other somatostatin receptor 2 (SSTR2)-expressing cancers....
2.
Jacob J, Anami Y, High P, Liang Z, Subramanian S, Ghosh S, et al.
Cancer Res
. 2024 Dec;
85(5):973-986.
PMID: 39693606
As colorectal cancer remains a leading cause of cancer-related death, identifying therapeutic targets and approaches is essential to improve patient outcomes. The EGFR ligand epiregulin (EREG) is highly expressed in...
3.
Jacob J, Anami Y, High P, Liang Z, Subramanian S, Ghosh S, et al.
bioRxiv
. 2024 Nov;
PMID: 39605519
As colorectal cancer (CRC) remains a leading cause of cancer-related death, identifying therapeutic targets and approaches is essential to improve patient outcomes. The EGFR ligand epiregulin (EREG) is highly expressed...
4.
Khalaj V, AghaAmiri S, Ghosh S, Vargas S, Momeny M, Azhdarinia A
Biotechniques
. 2024 Aug;
76(7):343-351.
PMID: 39185783
O-Methylguanine-DNA methyltransferase (MGMT) is a DNA repair enzyme that is overexpressed in certain tumors and is associated with resistance to the DNA alkylating agent temozolomide. MGMT inhibitors show potential in...
5.
AghaAmiri S, Ghosh S, Vargas S, Halperin D, Azhdarinia A
J Med Chem
. 2024 Feb;
67(4):2425-2437.
PMID: 38346097
Temozolomide (TMZ) is a DNA alkylating agent that produces objective responses in patients with neuroendocrine tumors (NETs) when the DNA repair enzyme O-methylguanine-DNA methyltransferase (MGMT) is inactivated. At high doses,...
6.
AghaAmiri S, Estrella J, Vargas S, Hurd M, Ghosh S, Azhdarinia A, et al.
Mol Imaging Biol
. 2024 Jan;
26(2):191-194.
PMID: 38267640
No abstract available.
7.
Sullivan T, Vargas S, Ghosh S, AghaAmiri S, Ikoma N, Azhdarinia A
Curr Opin Chem Biol
. 2023 Aug;
76:102376.
PMID: 37572489
Cancer imaging is a rapidly evolving field due to the discovery of novel molecular targets and the availability of corresponding techniques to detect them with high precision, accuracy, and sensitivity....
8.
Daigle N, Knapp T, Duan S, Jones Jr D, Azhdarinia A, Ghosh S, et al.
bioRxiv
. 2023 Feb;
PMID: 36778307
Pancreatic neuroendocrine tumors (PNETs) are a rare but increasingly more prevalent cancer with heterogeneous clinical and pathological presentation. Surgery is the preferred treatment for all hormone-expressing PNETs and any PNET...
9.
Vargas S, AghaAmiri S, Ghosh S, Luciano M, Borbon L, Ear P, et al.
Mol Pharm
. 2022 Sep;
19(11):4241-4253.
PMID: 36174110
Dye design can influence the ability of fluorescently labeled imaging agents to generate tumor contrast and has become an area of significant interest in the field of fluorescence-guided surgery (FGS)....
10.
Tran C, Borbon L, Mudd J, Abusada E, AghaAmiri S, Ghosh S, et al.
Cancers (Basel)
. 2022 Apr;
14(8).
PMID: 35454817
Gastroenteropancreatic neuroendocrine neoplasms (GEP NENs) are rare cancers consisting of neuroendocrine carcinomas (NECs) and neuroendocrine tumors (NETs), which have been increasing in incidence in recent years. Few cell lines and...